Bromocriptine use is associated with decreased smoking rates.
Dopaminergic transmission in the central nervous system is thought to underlie addictive behaviours, including smoking. One effective smoking cessation drug, bupropion, enhances dopaminergic transmission; conversely, antipsychotic drugs, which are dopamine antagonists, are associated with increased...
Päätekijät: | Murphy, M, Hey, K, Johnstone, E, Munafo, M, Walton, R, Willis, B, Harrison, P |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
2002
|
Samankaltaisia teoksia
-
Association of the mu-opioid receptor gene with smoking cessation.
Tekijä: Munafò, MR, et al.
Julkaistu: (2007) -
The genetic basis for smoking behavior: a systematic review and meta-analysis.
Tekijä: Munafò, M, et al.
Julkaistu: (2004) -
Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial.
Tekijä: Johnstone, E, et al.
Julkaistu: (2007) -
Association of COMT Val108/158Met genotype with smoking cessation.
Tekijä: Munafò, MR, et al.
Julkaistu: (2008) -
Central Hyperthermia Treated with Bromocriptine
Tekijä: P. Natteru, et al.
Julkaistu: (2017-01-01)